A single inhalation of vapor from dried toad secretion containing 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) in a naturalistic setting is related to sustained enhancement of satisfaction with life, mindfulness-related capacities, and a decrement of psychopathological symptoms.
Malin V. Uthaug, R. Lancelotta, Kim van Oorsouw, K. P. C. Kuypers, Natasha L. Mason, J. Rak, Anna Šuláková, Radek Jurok, Michal Maryška, Martin Kuchař, Tomáš Páleníček, Jordi Riba, J. G. Ramaekers
Psychopharmacology April 13, 2019 DOI: 10.1007/s00213-019-05236-w (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Observational cohort Peer reviewed |
|---|---|
| Sample size | 42 |
| Population | Volunteers who inhaled vapor from dried toad secretion at several European locations |
| Duration | Assessments at baseline, within 24 hours, and 4 weeks following intake |
| Topics | 5-MeO-DMT DMT Meditation |
| Keywords | Mental health Psychological health Emotional well-being Mental wellness Psychological well-being Emotional health Inner peace Contentment Satisfaction Psychedelics Entheogens Hallucinogens Psychotropic compounds Mind-altering substances Consciousness-expanding substances Visionary compounds Natural remedies Alternative therapy Holistic health Complementary medicine Natural compounds Herbal medicine Traditional medicine Research study Scientific research Clinical trial Investigation Experiment Academic study |
| Citations | 198 |
| Key findings | A single inhalation of vapor from dried toad secretion containing 5-MeO-DMT was followed by significant increases in satisfaction with life and convergent thinking at 24 hours that persisted at four weeks, increased mindfulness at four weeks, and decreased depression, anxiety, and stress reaching significance at four weeks. Higher ego dissolution or oceanic boundlessness during the session was associated with greater life satisfaction and lower depression and stress. The authors argue these results warrant exploratory research into therapeutic applications of 5-MeO-DMT. |
Abstract
Background: 5-methoxy-N,N-dimethyltryptamine (hereinafter referred to as 5-MeO-DMT) is a psychedelic substance found in the secretion from the parotoid glands of the Bufo alvarius toad. Inhalation of vapor from toad secretion containing 5-MeO-DMT has become popular in naturalistic settings as a treatment of mental health problems or as a means for spiritual exploration. However, knowledge of the effects of 5-MeO-DMT in humans is limited.
Aims: The first objective of this study was to assess sub-acute and long-term effects of inhaling vapor from dried toad secretion containing 5-MeO-DMT on affect and cognition. The second objective was to assess whether any changes were associated with the psychedelic experience.
Methods: Assessments at baseline, within 24 h and 4 weeks following intake, were made in 42 individuals who inhaled vapor from dried toad secretion at several European locations.
Results: Relative to baseline, ratings of satisfaction with life and convergent thinking significantly increased right after intake and were maintained at follow-up 4 weeks later. Ratings of mindfulness also increased over time and reached statistical significance at 4 weeks. Ratings of depression, anxiety, and stress decreased after the session, and reached significance at 4 weeks. Participants that experienced high levels of ego dissolution or oceanic boundlessness during the session displayed higher ratings of satisfaction with life and lower ratings of depression and stress.
Conclusion: A single inhalation of vapor from dried toad secretion containing 5-MeO-DMT produces sub-acute and long-term changes in affect and cognition in volunteers. These results warrant exploratory research into therapeutic applications of 5-MeO-DMT.
In the evidence
This study is part of the evidence base for 2 syntheses in the library. Here is how each one recorded it.
-
State of the evidence: 5-MeO-DMT Supports
A single inhalation was followed by significant increases in satisfaction with life and convergent thinking at 24 hours persisting at four weeks, increased mindfulness at four weeks, and decreased depression, anxiety, and stress reaching significance at four weeks, with greater ego dissolution associated with better outcomes.
Synthesized
-
State of the evidence: DMT Supports
A single inhalation of 5-MeO-DMT-containing toad vapor was followed by increased satisfaction with life and convergent thinking at 24 hours persisting at four weeks, increased mindfulness and decreased depression, anxiety, and stress at four weeks.
Synthesized
Comparable studies
Other observational and cohort studies on 5-MeO-DMT, most cited first.
Citations in the library
Cited by 170
- Me, myself, bye: regional alterations in glutamate and the experience of ego dissolution with psilocybin. Neuropsychopharmacology November 1, 2020
- Long-term effects of psychedelic drugs: A systematic review Neuroscience & Biobehavioral Reviews March 16, 2020
- Predicting Reactions to Psychedelic Drugs: A Systematic Review of States and Traits Related to Acute Drug Effects. ACS Pharmacology & Translational Science March 5, 2021
- Psychedelics in Psychiatry: Neuroplastic, Immunomodulatory, and Neurotransmitter Mechanisms Pharmacological Reviews December 16, 2020
- Psychedelic Communitas: Intersubjective Experience During Psychedelic Group Sessions Predicts Enduring Changes in Psychological Wellbeing and Social Connectedness. Frontiers in Pharmacology March 25, 2021
and 165 more in the library
Cites 33
- Using Self-Report Assessment Methods to Explore Facets of Mindfulness Assessment January 27, 2006
- Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial Journal of Psychopharmacology November 30, 2016
- Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial Journal of Psychopharmacology November 30, 2016
- Synaptic Dysfunction in Depression: Potential Therapeutic Targets Science October 4, 2012
- Human hallucinogen research: guidelines for safety. Journal of Psychopharmacology July 1, 2008
and 28 more in the library